Latest Market Challenges News

Lindsay Australia Limited reported a 31.5% rise in net profit after tax to A$22.9 million for FY26, driven by full-year SRT Logistics integration and organic growth. The company declared a fully franked 1.7 cent final dividend and secured a major Woolworths secondary freight contract in North Queensland.

Capral Limited posted a solid first half for 2026 with revenue rising 14% on higher aluminium prices and volume growth, while earnings remained steady despite cost pressures and subdued residential demand.

Powerhaus Uranium launches an IPO to raise up to A$10 million, aiming to accelerate uranium exploration in underexplored Argentine provinces and acquire a Canadian Athabasca Basin project. The company’s flagship Malbec Project shows promising early-stage results, with plans for extensive drilling and in-situ recovery methods.

Peter Warren Automotive reported a modest revenue increase to AUD 2.489 billion in FY26 but saw profit after tax nearly halve to AUD 6.3 million, reflecting margin pressure in new vehicles and rising operating costs. The company declared a fully franked final dividend of 0.6 cents per share and is poised for growth with expanded Chinese brand exposure and a disciplined acquisition pipeline.

WCM Global Growth reported a $66.7 million profit for FY2026, slightly down from last year, but boosted its final dividend and outlined a progressive dividend increase plan while completing a major $84.8 million capital raising.

Universal Store Holdings (ASX:UNI) posted a 12.9% revenue increase to $376.1 million in FY26, driven by strong like-for-like sales and store expansion. Underlying EBIT climbed 17.2% despite a $23.8 million impairment on CTC assets, while net profit after tax fell 21.6%. CEO Alice Barbery will retire in October, succeeded by George Do.

Ironbark Balanced Income Limited reported a 5.6% decline in net profit to $2.89 million for FY2026, while its investment portfolio delivered a solid 7.8% return, outperforming its benchmark and maintaining fully franked dividends.

Percheron Therapeutics reduced its FY2026 loss to $4.79 million as it prepares to launch a pivotal phase II trial for its immuno-oncology drug HMBD-002, while managing a CEO transition and tightening cash reserves.

NextEd Group navigated a tough international education market in FY26, boosting underlying EBITDA by 7% to $15.3 million even as revenue fell 6.7%. A $13 million goodwill impairment weighed on net losses, but ongoing cost discipline and vocational course growth underpin a resilient platform.

Ignite Limited reported an 18.8% drop in revenue to $73.2 million and a 29.4% fall in statutory profit to $0.87 million for FY2026, while maintaining a 13% gross margin and declaring a fully franked final dividend.

Reliance Worldwide Corporation has agreed to an exclusivity period with Brookfield Capital Partners over a A$4.75 per share acquisition proposal, valuing the company at around A$4.1 billion. The deal includes a 30-day go-shop provision allowing alternative bids.

Vita Life Sciences delivered a robust first half in 2026 with revenue up 6.1% to A$48.3 million and net profit after tax rising 14.9% to A$5.54 million. The company declared a higher interim dividend, reflecting improved margins and regional market momentum.